After oral glucocorticoids treatment, the patient’s delirium symptoms are alleviated, but other symptoms remained, the anti-DPPX antibody titer remained at 1:32, and the anti-CASPR2 antibody disappeared. The gene discussed is CNTNAP2; the disease is delirium.